Thursday, January 19, 2012

FDA Won't Approve BMS-Astra Diabetes Drug Just Yet - Jan. 19, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, January 19, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Partnerships 2012:
The Largest Yet Most Intimate Gathering of Clinical Decision Makers in the World


The world has radically changed in just the last few years and the trend is likely to continue at an exponential rate. Partnerships in Clinical Trials is changing with it. Partnerships has always been where business gets done and strategic partnership deals are inked, but in 2012 it is where the industry moves forward with answers. We've taken your most pressing challenges and translated them into the most provocative meeting agenda the industry has ever seen.

For more information, please visit the conference site: http://www.iirusa.com/cropartners/welcome-to-CROs.xml?registration=XP1700BSENL.
HeadHtml
•  FDA Won't Approve AstraZeneca PLC (AZN)-Bristol-Myers Squibb Company (BMY) Diabetes Drug Just Yet More...
•  FDA Approves Gilead Sciences, Inc. (GILD) NDA for Viread in HIV-Infected Children More...
More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Eisai Company, Ltd. (ESALY.PK) Receives Approval to Market Insomnia Treatment Lunesta in Japan More...
More Drug Approval News
HeadHtml
•  Bristol-Myers Squibb Company (BMY) Hepatitis C Pills Clear Virus Without Injections More...
•  Roche (RHHBY) Melanoma Drug Spurs Growth of Other Skin Cancers: Study More...
•  4SC AG (VSC.F) Says Its Resminostat Meets Primary Endpoint In Phase II Trial; Stock Rises +0.57(38.51%) @ 11:36AM EST More...
•  Sandoz, Inc. Initiates Two More Phase III Amgen (AMGN) Biosimilar Trials More...
•  Ferrer Internacional Initiates Phase III Clinical Studies for Novel Antibacterial Compound, Ozenoxacin, in Development as a Topical Treatment for Impetigo and Other Infectious Dermatological Conditions More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
HeadHtml
•  University of California, Berkeley (CAL) Gossip Study Finds It's a Good Thing More...
•  Boston University Researchers Identify Genetic Signatures of Exceptional Longevity in Re-Published Study More...
•  Sleep Might Help Deepen Traumatic Memories, University of Massachusetts - Amherst Study More...
•  Genes May Guide Intelligence Throughout Life, University of Edinburgh Study More...
•  "Upper Normal" Blood Pressure Linked to Heart Risk in Men, University of Oslo Study More...
More General Clinical Research News
Events

SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively)

The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication.

The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization.

COURSE SEATING IS LIMITED AND USUALLY SELLS OUT!

San Diego, CA
Boot Camp I May 15-16, 2012
Boot Camp II May 17, 2012

Contact Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com
Latest Market Insight

Innovative Clinical Trial Design and Management

• Use detailed case studies of recent adaptive trials featuring companies including Merck, Pfizer, Novartis, GSK, Eli Lilly, and AstraZeneca.
• Measure the potential cost savings offered by the reduced development times and improved decision-making associated with adaptive trials
• Assess the logistics of adaptive trial implementations.

Click Here for More Information.
Tower: Facebook
Top Jobs
Biotech Bay (San Francisco, California)

Sprim
Clinical Trial Manager
Will manage multiple studies and sites, working with US sponsors, US sites, and international Sprim offices. Will require taking on a broad range of responsibilities from basic project administration to clinical trial leadership.

Biotech Beach (Carlsbad, California)

Genoptix, Inc.
Clinical Molecular Technologist II/Senior Clinical Molecular Technologist
Will analyze human blood and bone marrow specimens submitted for evaluation of a variety of hematological malignancies such as leukemias, lymphoma and myelomas.

Genetown (Cambridge, Massachusetts)

Sanofi
Clinical Scientist
Contribute to (assist the clinical lead in) the clinical development plans for new compounds in collaboration with the project MD or project head, including review of the preclinical package.

BioMidwest (Chicago, Illinois)

AVEO Pharmaceuticals, Inc.
Regional Senior Clinical Research Associate
Responsible for monitoring the progress of clinical oncology studies at investigative sites, and ensuring that clinical studies are conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), ICH-GCP, and all applicable regulatory requirements.

Pharm Country (Wayne, Pennsylvania)

Octagon Research Solutions, Inc.
Clinical Programming Manager
Will provide leadership in the creation and validation of SAS programs in support of sponsors clinical trials; ensuring that the SOPs and guidelines are followed in creating the derived clinical databases and data displays to high quality and per agreed timelines.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Genetown

Genetown Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Genetown Career Fair, Cambridge, MA February 21, 2012
BioSpace Career Fair at CALBIO2012, San Francisco, CA March 7, 2012
BioMidwest Career Fair, Bridgewater, NJ March 22, 2012
Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient More...
More Patent News
Feature

Hot Company

Gentris Corporation
133 Southcenter Court, Suite 400
Morrisville, North Carolina 27560 U.S.A.
Phone: 919-465-0100 Fax: 919-465-0554

Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services. As pioneers in the field of pharmacogenomics, Gentris assists pharmaceutical companies and clinical research organizations to effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective drugs to market more quickly.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: